Clinical trial

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

NCT01185028

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2021-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C Infectionunresolved

HIV Infectionunresolved

Interventions

Nitazoxanide With Pegylated Interferon And RibavirinDRUG

Sponsors & collaborators

National Institutes of Health Clinical Center (CC)lead sponsor

Mapped research locations

Washington D.C.District of Columbia, United States3 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01185028 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.